Blepharophimosis with intellectual disability and Helsmoortel-Van Der Aa Syndrome share episignature and phenotype.

ADNP Helsmoortel‐Van Der Aa Syndrome SMARCA2 blepharophimosis with intellectual disability

Journal

American journal of medical genetics. Part C, Seminars in medical genetics
ISSN: 1552-4876
Titre abrégé: Am J Med Genet C Semin Med Genet
Pays: United States
ID NLM: 101235745

Informations de publication

Date de publication:
17 Jun 2024
Historique:
revised: 10 04 2024
received: 21 12 2023
accepted: 11 05 2024
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: aheadofprint

Résumé

Blepharophimosis with intellectual disability (BIS) is a recently recognized disorder distinct from Nicolaides-Baraister syndrome that presents with distinct facial features of blepharophimosis, developmental delay, and intellectual disability. BIS is caused by pathogenic variants in SMARCA2, that encodes the catalytic subunit of the superfamily II helicase group of the BRG1 and BRM-associated factors (BAF) forming the BAF complex, a chromatin remodeling complex involved in transcriptional regulation. Individuals bearing variants within the bipartite nuclear localization (BNL) signal domain of ADNP present with the neurodevelopmental disorder known as Helsmoortel-Van Der Aa Syndrome (HVDAS). Distinct DNA methylation profiles referred to as episignatures have been reported in HVDAS and BAF complex disorders. Due to molecular interactions between ADNP and BAF complex, and an overlapping craniofacial phenotype with narrowing of the palpebral fissures in a subset of patients with HVDAS and BIS, we hypothesized the possibility of a common phenotype-specific episignature. A distinct episignature was shared by 15 individuals with BIS-causing SMARCA2 pathogenic variants and 12 individuals with class II HVDAS caused by truncating pathogenic ADNP variants. This represents first evidence of a sensitive phenotype-specific episignature biomarker shared across distinct genetic conditions that also exhibit unique gene-specific episignatures.

Identifiants

pubmed: 38884529
doi: 10.1002/ajmg.c.32089
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e32089

Subventions

Organisme : Telethon Foundation, Telethon Undiagnosed Diseases Program
Organisme : Genome Canada and the Ontario Genomics Institute

Informations de copyright

© 2024 The Author(s). American Journal of Medical Genetics Part C: Seminars in Medical Genetics published by Wiley Periodicals LLC.

Références

Aref‐Eshghi, E., Bend, E. G., Colaiacovo, S., Caudle, M., Chakrabarti, R., Napier, M., Brick, L., Brady, L., Carere, D. A., Levy, M. A., Kerkhof, J., Stuart, A., Saleh, M., Beaudet, A. L., Li, C., Kozenko, M., Karp, N., Prasad, C., Siu, V. M., … Sadikovic, B. (2019). Diagnostic utility of genome‐wide DNA methylation testing in genetically unsolved individuals with suspected hereditary conditions. American Journal of Human Genetics, 104(4), 685–700.
Aref‐Eshghi, E., Kerkhof, J., Pedro, V. P., Barat‐Houari, M., Ruiz‐Pallares, N., Andrau, J. C., Lacombe, D., Van‐Gils, J., Fergelot, P., Dubourg, C., & Cormier‐Daire, V. (2020). Evaluation of DNA methylation episignatures for diagnosis and phenotype correlations in 42 Mendelian neurodevelopmental disorders. American Journal of Human Genetics, 106(3), 356–370.
Aryee, M. J., Jaffe, A. E., Corrada‐Bravo, H., Ladd‐Acosta, C., Feinberg, A. P., Hansen, K. D., & Irizarry, R. A. (2014). Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics, 30(10), 1363–1369.
Bend, E. G., Aref‐Eshghi, E., Everman, D. B., Rogers, R. C., Cathey, S. S., Prijoles, E. J., Lyons, M. J., Davis, H., Clarkson, K., Gripp, K. W., Li, D., Bhoj, E., Zackai, E., Mark, P., Hakonarson, H., Demmer, L. A., Levy, M. A., Kerkhof, J., Stuart, A., … Sadikovic, B. (2019). Gene domain‐specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome. Clinical Epigenetics, 11(1), 64.
Breen, M. S., Garg, P., Tang, L., Mendonca, D., Levy, T., Barbosa, M., Arnett, A. B., Kurtz‐Nelson, E., Agolini, E., Battaglia, A., Chiocchetti, A. G., Freitag, C. M., Garcia‐Alcon, A., Grammatico, P., Hertz‐Picciotto, I., Ludena‐Rodriguez, Y., Moreno, C., Novelli, A., Parellada, M., … deRubeis, S. (2020). Episignatures stratifying Helsmoortel‐Van Der aa syndrome show modest correlation with phenotype. American Journal of Human Genetics, 107(3), 555–563.
Cappuccio, G., Sayou, C., Tanno, P. L., Tisserant, E., Bruel, A. L., Kennani, S. E., Sá, J., Low, K. J., Dias, C., Havlovicová, M., Hančárová, M., Eichler, E. E., Devillard, F., Moutton, S., vanGils, J., Dubourg, C., Odent, S., Gerard, B., Piton, A., … Brunetti‐Pierri, N. (2020). De novo SMARCA2 variants clustered outside the helicase domain cause a new recognizable syndrome with intellectual disability and blepharophimosis distinct from Nicolaides‐Baraitser syndrome. Genetics in Medicine, 22(11), 1838–1850.
Cappuyns, E., Huyghebaert, J., Vandeweyer, G., & Kooy, R. F. (2018). Mutations in ADNP affect expression and subcellular localization of the protein. Cell Cycle, 17(9), 1068–1075.
Cardoso, M. A., Rizzardi, L. E. A., Kume, L. W., Groeneveld, C. S., Trefflich, S., Morais, D. A. A., Dalmolin, R. J. S., Ponder, B. A. J., Meyer, K. B., & Castro, M. A. A. (2022). TreeAndLeaf: An R/Bioconductor package for graphs and trees with focus on the leaves. Bioinformatics, 38(5), 1463–1464.
Cavalcante, R. G., & Sartor, M. A. (2017). Annotatr: Genomic regions in context. Bioinformatics, 33(15), 2381–2383.
D'Incal, C. P., Van Rossem, K. E., De Man, K., Konings, A., Van Dijck, A., Rizzuti, L., Vitriolo, A., Testa, G., Gozes, I., Vanden Berghe, W., & Kooy, R. F. (2023). Chromatin remodeler activity‐dependent neuroprotective protein (ADNP) contributes to syndromic autism. Clinical Epigenetics, 15(1), 45.
Ganaiem, M., Karmon, G., Ivashko‐Pachima, Y., & Gozes, I. (2022). Distinct impairments characterizing different ADNP mutants reveal aberrant cytoplasmic‐nuclear crosstalk. Cells, 11(19), 2994.
Gu, Z., Gu, L., Eils, R., Schlesner, M., & Brors, B. (2014). Circlize implements and enhances circular visualization in R. Bioinformatics, 30(19), 2811–2812.
Helsmoortel, C., Vulto‐van Silfhout, A. T., Coe, B. P., Vandeweyer, G., Rooms, L., van denEnde, J., Schuurs‐Hoeijmakers, J. H., Marcelis, C. L., Willemsen, M. H., Vissers, L. E., & Yntema, H. G. (2014). A SWI/SNF‐related autism syndrome caused by de novo mutations in ADNP. Nature Genetics, 46(4), 380–384.
Ho, D., Imai, K., King, G., & Stuart, E. A. (2011). MatchIt: Nonparametric preprocessing for parametric causal inference. Journal of Statistical Software., 42(8), 1–28.
Krajewska‐Walasek, M., Jurkiewicz, D., Piekutowska‐Abramczuk, D., Kucharczyk, M., Chrzanowska, K. H., Jezela‐Stanek, A., & Ciara, E. (2016). Additional data on the clinical phenotype ofHelsmoortel‐Van der Aa syndrome associated with a novel truncating mutation inADNP gene. American Journal of Medical Genetics. Part A. 170(6), 1647–1650.
Levy, M. A., McConkey, H., Kerkhof, J., Barat‐Houari, M., Bargiacchi, S., Biamino, E., Bralo, M. P., Cappuccio, G., Ciolfi, A., Clarke, A., DuPont, B., Elting, M. W., Faivre, L., Fee, T., Fletcher, R. S., Cherik, F., Foroutan, A., Friez, M. J., Gervasini, C., … Sadikovic, B. (2022). Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders. HGG Adv, 3(1), 100075.
Levy, M. A., Relator, R., McConkey, H., Pranckeviciene, E., Kerkhof, J., Barat‐Houari, M., Bargiacchi, S., Biamino, E., Palomares Bralo, M., Cappuccio, G., Ciolfi, A., Clarke, A., DuPont, B. R., Elting, M. W., Faivre, L., Fee, T., Ferilli, M., Fletcher, R. S., Cherick, F., … Sadikovic, B. (2022). Functional correlation of genome‐wide DNA methylation profiles in genetic neurodevelopmental disorders. Human Mutation, 43, 1609–1628.
Oz, S., Ivashko‐Pachima, Y., & Gozes, I. (2012). The ADNP derived peptide, NAP modulates the tubulin pool: Implication for neurotrophic and neuroprotective activities. PLoS ONE, 7(12), e51458.
Pascolini, G., Agolini, E., Majore, S., Novelli, A., Grammatico, P., & Digilio, M. C. (2018). Helsmoortel‐Van der Aa Syndrome as emerging clinical diagnosis in intellectually disabled children with autistic traits and ocular involvement. Eur J Paediatr Neurol. 22(3), 552–557.
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier‐Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., & Voelkerding, K. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405–424.
Riggs, E. R., Andersen, E. F., Cherry, A. M., Kantarci, S., Kearney, H., Patel, A., Raca, G., Ritter, D. I., South, S. T., Thorland, E. C., Pineda‐Alvarez, D., Aradhya, S., & Martin, C. L. (2020). Technical standards for the interpretation and reporting of constitutional copy‐number variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the clinical genome resource (ClinGen). Genetics in Medicine, 22(2), 245–257.
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015). Limma powers differential expression analyses for RNA‐sequencing and microarray studies. Nucleic Acids Research, 43(7), e47.
Rooney, K., van derLaan, L., Trajkova, S., Haghshenas, S., Relator, R., Lauffer, P., Vos, N., Levy, M. A., Brunetti‐Pierri, N., Terrone, G., Mignot, C., Keren, B., deVillemeur, T. B., Volker‐Touw, C. M. L., Verbeek, N., van derSmagt, J. J., Oegema, R., Brusco, A., Ferrero, G. B., … Henneman, P. (2023). DNA methylation episignature and comparative epigenomic profiling of HNRNPU‐related neurodevelopmental disorder. Genetics in Medicine, 25(8), 100871.
Sadikovic, B., Aref‐Eshghi, E., Levy, M. A., & Rodenhiser, D. (2019). DNA methylation signatures in mendelian developmental disorders as a diagnostic bridge between genotype and phenotype. Epigenomics, 11(5), 563–575.
Sadikovic, B., Levy, M. A., Kerkhof, J., Aref‐Eshghi, E., Schenkel, L., Stuart, A., McConkey, H., Henneman, P., Venema, A., Schwartz, C. E., Stevenson, R. E., Skinner, S. A., DuPont, B. R., Fletcher, R. S., Balci, T. B., Siu, V. M., Granadillo, J. L., Masters, J., Kadour, M., … Alders, M. (2021). Clinical epigenomics: Genome‐wide DNA methylation analysis for the diagnosis of Mendelian disorders. Genetics in Medicine, 23(6), 1065–1074.
Sun, X., Yu, W., Li, L., & Sun, Y. (2020). ADNP controls gene expression through local chromatin architecture by association with BRG1 and CHD4. Frontiers in Cell and Development Biology, 8, 553.
Takenouchi, T., Miwa, T., Sakamoto, Y., Sakaguchi, Y., Uehara, T., Takahashi, T., & Kosaki, K. (2017). Further evidence that ablepharophimosis syndrome phenotype is associated with a specific class ofmutation in the ADNP gene. American Journal of Medical Genetics Part A, 173(6), 1631–1634.
van derLaan, L., Rooney, K., Alders, M., Relator, R., McConkey, H., Kerkhof, J., Levy, M. A., Lauffer, P., Aerden, M., Theunis, M., Legius, E., Tedder, M. L., Vissers, L. E. L. M., Koene, S., Ruivenkamp, C., Hoffer, M. J. V., Wieczorek, D., Bramswig, N. C., Herget, T., … Henneman, P. (2022). Episignature mapping of TRIP12 provides functional insight into Clark–Baraitser syndrome. International Journal of Molecular Sciences., 23(22), 13664.
Van Dijck, A., Vulto‐van Silfhout, A. T., Cappuyns, E., van derWerf, I. M., Mancini, G. M., Tzschach, A., Bernier, R., Gozes, I., Eichler, E. E., Romano, C., & Lindstrand, A. (2019). Clinical presentation of a complex neurodevelopmental disorder caused by mutations in ADNP. Biological Psychiatry, 85(4), 287–297.
Vandeweyer, G., Helsmoortel, C., Van Dijck, A., Vulto‐van Silfhout, A. T., Coe, B. P., Bernier, R., Gerdts, J., Rooms, L., Van Den Ende, J., Bakshi, M., & Wilson, M. (2014). The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 166c(3), 315–326.
Weiss, K., Lazar, H. P., Kurolap, A., Martinez, A. F., Paperna, T., Cohen, L., Smeland, M. F., Whalen, S., Heide, S., Keren, B., Terhal, P., Irving, M., Takaku, M., Roberts, J. D., Petrovich, R. M., Schrier Vergano, S. A., Kenney, A., Hove, H., DeChene, E., … Lachlan, K. (2020). The CHD4‐related syndrome: A comprehensive investigation of the clinical spectrum, genotype‐phenotype correlations, and molecular basis. Genetics in Medicine, 22(2), 389–397.

Auteurs

Camilla Sarli (C)

Department of Translational Medicine, Federico II University of Naples, Naples, Italy.

Liselot van der Laan (L)

Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Jack Reilly (J)

Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.

Slavica Trajkova (S)

Department of Medical Sciences, University of Torino, Turin, Italy.
Molecular Biotechnology Center "Guido Tarone", University of Turin, Turin, Italy.

Diana Carli (D)

Department of Medical Sciences, University of Torino, Turin, Italy.

Alfredo Brusco (A)

Department of Medical Sciences, University of Torino, Turin, Italy.
Medical Genetics Unit, Città della Salute e della Scienza University Hospital, Turin, Italy.
Department of Neurosciences Rita Levi-Montalcini, University of Turin, Turin, Italy.

Michael A Levy (MA)

Verspeeten Clinical Genome Centre, London Health Science Centre, London, Ontario, Canada.

Raissa Relator (R)

Verspeeten Clinical Genome Centre, London Health Science Centre, London, Ontario, Canada.

Jennifer Kerkhof (J)

Verspeeten Clinical Genome Centre, London Health Science Centre, London, Ontario, Canada.

Haley McConkey (H)

Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
Verspeeten Clinical Genome Centre, London Health Science Centre, London, Ontario, Canada.

Matthew L Tedder (ML)

Greenwood Genetic Center, Greenwood, South Carolina, USA.

Cindy Skinner (C)

Greenwood Genetic Center, Greenwood, South Carolina, USA.

Mariëlle Alders (M)

Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Peter Henneman (P)

Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Raoul C M Hennekam (RCM)

Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Claudia Ciaccio (C)

Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Stefano D'Arrigo (S)

Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Antonio Vitobello (A)

Department of Genetics, UNICAEN, Caen University Hospital, Normandy University, Caen, France.

Laurence Faivre (L)

Université de Bourgogne, Inserm U1231, Equipe GAD, Dijon, France.
CHU Dijon Bourgogne, Centre de Génétique, Centre de Référence Maladies Rares "Anomalies du Développement et Syndromes Malformatifs", FHU-TRANSLDAD, Dijon, France.

Sacha Weber (S)

Service de Génétique, CHU de Caen-Normandie, Caen, France.
Service de Neurologie, CHU de Caen-Normandie, Caen, France.

Aline Vincent-Devulder (A)

Department of Genetics, UNICAEN, Caen University Hospital, Normandy University, Caen, France.

Laurence Perrin (L)

Department of Genetics, UNICAEN, Caen University Hospital, Normandy University, Caen, France.

Alexia Bourgois (A)

Department of Genetics, UNICAEN, Caen University Hospital, Normandy University, Caen, France.

Toshiyuki Yamamoto (T)

Division of Gene Medicine, Graduate School of Medical Science, Tokyo Women's Medical University, Tokyo, Japan.

Kay Metcalfe (K)

Manchester Centre for Genomic Medicine, St Mary's Hospital, Health Innovation Manchester, Manchester University Foundation NHS Trust, Manchester, UK.
Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Marcella Zollino (M)

Institute of Genomic Medicine, Department of Life Sciences and Public Health, 'Sacro Cuore' Catholic University of Rome, Rome, Italy.
Medical Genetics Unit, Foundation IRCCS AOU Policlinico 'A. Gemelli', Rome, Italy.

Usha Kini (U)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Daniela Oliveira (D)

Medical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

Sergio B Sousa (SB)

Medical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

Denise Williams (D)

Department of Clinical Genetics, Birmingham Women's & Children's NHS Foundation Trust, Birmingham, UK.

Gerarda Cappuccio (G)

Department of Translational Medicine, Federico II University of Naples, Naples, Italy.

Bekim Sadikovic (B)

Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
Verspeeten Clinical Genome Centre, London Health Science Centre, London, Ontario, Canada.

Nicola Brunetti-Pierri (N)

Department of Translational Medicine, Federico II University of Naples, Naples, Italy.
Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
Scuola Superiore Meridionale (SSM, School of Advanced Studies), Genomics and Experimental Medicine Program, University of Naples Federico II, Naples, Italy.

Classifications MeSH